Mahatme Sandesh

CIK 00015110347 companiesSUMMIT, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001511034

Recent Transactions

50 trades

Disposition to Issuer
Vor Biopharma Inc.$VOR
Common Stock
2025-12-05−694,137→ 0 total
Award
Vor Biopharma Inc.$VOR
Employee Stock Option (right to buy)
2025-12-05+1,388,274→ 1,388,274 total
Award
Vor Biopharma Inc.$VOR
Common Stock
2025-07-09+13,882,750→ 13,882,750 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2025-06-05+13,000→ 13,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2024-05-30+13,000→ 13,000 total
Award
Spyre Therapeutics, Inc.$SYRE
Director Stock Option (right to buy)
2022-06-07+43,000→ 43,000 total
Award
Spyre Therapeutics, Inc.$SYRE
Director Stock Option (right to buy)
2021-06-08+40,000→ 40,000 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2020-07-08$32.63/sh−1,203→ 0 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2020-07-08$32.63/sh+1,203→ 20,260 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2020-07-08$13.71/sh+218→ 19,057 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2020-07-08$13.71/sh+2,385→ 18,839 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2020-07-08$13.71/sh−218→ 0 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2020-07-08$13.71/sh−2,385→ 0 total
Award
Flexion Therapeutics Inc
Stock option (right to buy)
2020-06-10+7,000→ 7,000 total
Award
Flexion Therapeutics Inc
Common Stock
2020-06-10+4,500→ 4,500 total
Award
Spyre Therapeutics, Inc.$SYRE
Director Stock Option (right to buy)
2020-06-08+28,100→ 28,100 total
Gift
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2020-05-11−20,425→ 16,454 total
Award
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2020-02-28+37,500→ 37,500 total
Award
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2020-02-28+6,700→ 36,879 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2019-12-13−14,723→ 39,277 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2019-12-13−69,479→ 0 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2019-12-13−10,466→ 0 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-12-13$34.92/sh+14,723→ 155,179 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-12-13$32.63/sh+21,875→ 140,456 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-12-13$23.85/sh+10,466→ 49,102 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2019-12-13−21,875→ 10,874 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-12-13$29.03/sh+69,479→ 118,581 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2019-12-13−4,138→ 2,633 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2019-12-13−4,319→ 3,085 total
Sale
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-12-13$125.50/sh−125,000→ 30,179 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-12-13$13.71/sh+4,138→ 38,636 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-12-13$13.71/sh+4,319→ 34,498 total
Gift
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-08-22−42,535→ 30,179 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock Appreciation Right
2019-08-21−100,000→ 0 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-08-21$101.50/sh−57,465→ 72,714 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-08-21$23.85/sh+100,000→ 130,179 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2019-08-15−3,021→ 0 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2019-08-15−985→ 2,385 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2019-08-15−2,863→ 0 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2019-08-15−2,625→ 0 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-08-15$13.90/sh+2,625→ 28,934 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2019-08-15−260→ 218 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-08-15$29.03/sh+3,021→ 26,309 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-08-15$13.71/sh+260→ 30,179 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-08-15$13.71/sh+985→ 29,919 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-08-15$34.92/sh+2,863→ 23,288 total
Award
Flexion Therapeutics Inc
Stock option (right to buy)
2019-06-19+12,500→ 12,500 total
Award
Spyre Therapeutics, Inc.$SYRE
Director Stock Option (right to buy)
2019-06-07+12,400→ 12,400 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-03-28$118.68/sh−2,953→ 20,425 total
Award
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-03-28+6,649→ 23,378 total

Companies

Recent Filings

Address

C/O STALAR 3, INC. 86 MORRIS AVENUE

SUMMIT, NJ, 07901

View on SEC.gov